3//SEC Filing
NeoMed Management (Jersey) Ltd 3
Accession 0000899243-17-026395
CIK 0001501697other
Filed
Nov 14, 7:00 PM ET
Accepted
Nov 15, 5:20 PM ET
Size
26.2 KB
Accession
0000899243-17-026395
Insider Transaction Report
Form 3
Arsanis, Inc.ASNS
NeoMed Innovation V L.P.
10% Owner
Holdings
Series C Convertible Preferred Stock
→ Common Stock (41,878 underlying)Series D Convertible Preferred Stock
→ Common Stock (279,079 underlying)Series B Convertible Preferred Stock
→ Common Stock (246,682 underlying)
NeoMed Management (Jersey) Ltd
10% Owner
Holdings
Series B Convertible Preferred Stock
→ Common Stock (246,682 underlying)Series C Convertible Preferred Stock
→ Common Stock (41,878 underlying)Series D Convertible Preferred Stock
→ Common Stock (279,079 underlying)
NeoMed Innovation V Ltd
10% Owner
Holdings
Series B Convertible Preferred Stock
→ Common Stock (246,682 underlying)Series C Convertible Preferred Stock
→ Common Stock (41,878 underlying)Series D Convertible Preferred Stock
→ Common Stock (279,079 underlying)
Footnotes (4)
- [F1]The Series B Convertible Preferred Stock is convertible into Common Stock on a 0.44650-for-one basis into the number of shares of Common Stock shown in column 3 at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering without payment of further consideration. The shares have no expiration date.
- [F2]The Series C Convertible Preferred Stock is convertible into Common Stock on a 0.49832-for-one basis into the number of shares of Common Stock shown in column 3 at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering without payment of further consideration. The shares have no expiration date.
- [F3]The Series D Convertible Preferred Stock is convertible into Common Stock on a 0.29300-for-one basis into the number of shares of Common Stock shown in column 3 at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering without payment of further consideration. The shares have no expiration date.
- [F4]The reported securities are held of record by NeoMed Innovation V L.P. NeoMed Management (Jersey) Limited is the Investment Manager to NeoMed Innovation V L.P. NeoMed Innovation V Limited is the general partner of Neomed Innovation V L.P. By virtue of such relationships, NeoMed Management (Jersey) Limited and NeoMed Innovation V Limited may be deemed to have voting and investment power with respect to the shares held by NeoMed Innovation V L.P. Each of NeoMed Management (Jersey) Limited and NeoMed Innovation V Limited disclaims beneficial ownership of the shares held by NeoMed Innovation V L.P., except to the extent of its or his pecuniary interest therein, if any.
Issuer
Arsanis, Inc.
CIK 0001501697
Entity typeother
IncorporatedJersey
Related Parties
1- filerCIK 0001722665
Filing Metadata
- Form type
- 3
- Filed
- Nov 14, 7:00 PM ET
- Accepted
- Nov 15, 5:20 PM ET
- Size
- 26.2 KB